| de novo | Anew; often applied to particular biochemical pathways in which metabolites are newly biosynthesised (e.g., de novo purine biosynthesis). Origin: L. (05 Mar 2000) |
|---|---|
| de novo pathway | <biochemistry> A pathway for synthesising a biomolecule from simple precursor molecules. Compare: salvage pathway. (12 Jan 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
¿¡½ºÆ®·ÎÆèÁ¤1mg - »õâ
|
Novo Nordisk |
E08720141 | Estradiol hemihydrate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Ŭ¸®¿ÀÁ¦½ºÆ®Á¤ - »õâ
|
Novo Nordisk |
E08720101 | Estradiol hemihydrate, Norethisterone acetate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Àν´¶óŸµåhmÆæÇÊÁÖ100´ÜÀ§/ml - »õâ
|
Novo Nordisk |
W08720051 | Human insulin | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
³ëº¸·¿¿£ÁÖ100´ÜÀ§/ml - »õâ
|
Novo Nordisk |
E08720011 | Human insulin | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
¹Í½ºÅ¸µå30hmÁÖ100´ÜÀ§/ml - »õâ
|
Novo Nordisk |
W08720041 | Human insulin | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
¹Í½ºÅ¸µå30hmÆæÇÊÁÖ100´ÜÀ§/ml - »õâ
|
Novo Nordisk |
W08720081 | Human insulin | Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
³ëº¸·¿30/70ÁÖ100´ÜÀ§/ml - »õâ
|
Novo Nordisk |
E08720051 | Human insulin | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
³ëº¸·¿20/80ÁÖ100´ÜÀ§/ml - »õâ
|
Novo Nordisk |
E08720041 | Human insulin | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
¹Í½ºÅ¸µå10hmÆæÇÊÁÖ100´ÜÀ§/ml - »õâ
|
Novo Nordisk |
W08720061 | Human insulin | Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
³ëº¸·¿10/90ÁÖ100´ÜÀ§/ml - »õâ
|
Novo Nordisk |
E08720031 | Human insulin | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|